Pediatrics

The FDA approved the first treatment for patients with congenital thrombotic thrombocytopenic purpura (cTTP), which is a rare and life-threatening blood clotting disorder that may be fatal if left...

A new set of guidelines detail recommendations for the best practice in managing acute dental pain in children after tooth extractions or during toothache.

Researchers evaluated the prevalence of depression disorders in pediatric patients to determine if there is a mental health impact on this age group.

This COVID-19 roundup includes coverage of the FDA’s guidance for the correct Moderna vaccine dosage for pediatric patients, COVID-19 outcomes for patients with hypertension and diabetes, and the risk of...

In a single-group trial, researchers assessed the safety and risks associated with interrupting endocrine therapy for women with stage I, II, or III breast cancer attempting pregnancy.

A team of researchers sought to find the effectiveness of high spinal anesthesia and general anesthesia in postoperative recovery times among pediatric patients undergoing congenital heart surgery.

Researchers aimed to quantify the amount of protection maternal COVID-19 boosters provide during the first 6 months of an infant’s life.

The FDA approved ustekinumab-auub as an interchangeable biosimilar with ustekinumab for multiple inflammatory diseases.

In late September, the FDA approved the first biosimilar to tocilizumab to treat adult and pediatric patients with various indications of arthritis.

Researchers evaluated the national trends in the United States to determine the frequency of anesthesia/sedation in pediatric patients undergoing CT or MRI in emergency departments.